Suboptimal exposure to fluconazole in critically ill patients: Pharmacokinetic analysis and determinants

被引:5
|
作者
Bienvenu, A. L. [1 ,2 ]
Pradat, P. [3 ]
Matusik, E. [1 ]
Piriou, V. [4 ]
Rimmele, T. [5 ]
Parant, F. [6 ]
Tod, M. [1 ,7 ,8 ]
Leboucher, G. [1 ]
Goutelle, S. [1 ,7 ,8 ]
机构
[1] Hosp Civils Lyon, Serv Pharm, Grp Hosp Nord, Lyon, France
[2] Univ Lyon, ICBMS CNRS 5246, Campus Lyon Tech La Doua, Lyon, France
[3] Hosp Civils Lyon, Ctr Rech Clin, Grp Hosp Nord, Lyon, France
[4] Hosp Civils Lyon, Serv Anesthesie Reanimat, Grp Hosp Sud, Lyon, France
[5] Hosp Civils Lyon, Grp Hosp Ctr, Serv Anesthesie Reanimat, Lyon, France
[6] Hosp Civils Lyon, Lab Biochim & Biol Mol, UM Pharmacotoxicol Grp Hosp Sud, Lyon, France
[7] Univ Lyon 1, Univ Lyon, Fac Pharm Lyon, ISPB, Lyon, France
[8] Univ Lyon 1, Univ Lyon, CNRS, UMR 5558,Lab Biometrie & Biol Evolut, Villeurbanne, France
来源
INFECTIOUS DISEASES NOW | 2023年 / 53卷 / 02期
关键词
Antifungal stewardship; Critically ill patients; Fluconazole; Pharmacokinetic; Therapeutic drug monitoring;
D O I
10.1016/j.idnow.2022.10.002
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives: This study aims at evaluating fluconazole exposure in critically ill patients and identifying variables associated with the latter.Patients and methods: This was a 2-year (2018-2019) retrospective multicenter cohort study. Adult patients > 18 years-old with at least one fluconazole concentration measurement during their ICU stay were included.Results: Twenty patients were included. Only 11 patients had a fluconazole trough concentration (Cmin) within the target range (>= 15 mg/L). According to bivariable analysis, SOFA score, GGT, fluconazole clear-ance, Ke, and Vd, were independently associated with a decrease in fluconazole Cmin. The median loading dose required to achieve the Cmin target appeared to be greater in patients with higher SOFA or GGT level and in patients undergoing renal replacement therapy.Conclusions: This study supports recommendation for routine fluconazole therapeutic drug monitoring in ICU patients so as to avoid underexposure, especially if SOFA score is >= 7 and/or GGT is >= 100 U/L.
引用
收藏
页数:4
相关论文
共 50 条
  • [1] Pharmacokinetic evaluation of fluconazole in critically ill patients
    Sinnollareddy, Mahipal
    Peake, Sandra L.
    Roberts, Michael S.
    Playford, E. Geoffrey
    Lipman, Jeffrey
    Roberts, Jason A.
    [J]. EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2011, 7 (11) : 1431 - 1440
  • [2] Pharmacokinetic Variability and Target Attainment of Fluconazole in Critically Ill Patients
    Van Daele, Ruth
    Wauters, Joost
    Lagrou, Katrien
    Denooz, Raphael
    Hayette, Marie-Pierre
    Gijsen, Matthias
    Brueggemann, Roger J.
    Debaveye, Yves
    Spriet, Isabel
    [J]. MICROORGANISMS, 2021, 9 (10)
  • [3] Determinants of gentamicin concentrations in critically ill patients: a population pharmacokinetic analysis
    Hodiamont, Caspar J.
    Juffermans, Nicole P.
    Bouman, Catherine S. C.
    de Jong, Menno D.
    Mathot, Ron A. A.
    van Hest, Reinier M.
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2017, 49 (02) : 204 - 211
  • [4] Might Confounding Factors Have an Effect on Suboptimal Dosing of Fluconazole in Critically Ill Patients?
    Kara, Emre
    Ekincioglu, Aygin Bayraktar
    Metan, Gokhan
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2021, 65 (02)
  • [5] Parametric and nonparametric population pharmacokinetic analysis of fluconazole in critically ill patients and dosing simulations for Candida infections
    Matusik, Elodie
    Vassal, Olivia
    Conrad, Anne
    Ferry, Tristan
    Millet, Aurelien
    Dupont, Damien
    Grandjean, Lola
    Guitton, Jerome
    Roux, Sandrine
    Bienvenu, Anne-Lise
    Bohe, Julien
    Friggeri, Arnaud
    Goutelle, Sylvain
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2024,
  • [6] Suboptimal Aminoglycoside Dosing in Critically Ill Patients
    Rea, Rhonda S.
    Capitano, Blair
    Bies, Robert
    Bigos, Kristin L.
    Smith, Randall
    Lee, Howard
    [J]. THERAPEUTIC DRUG MONITORING, 2008, 30 (06) : 674 - 681
  • [7] Suboptimal aminoglycoside dosing in critically ill patients
    Rea, RS
    Capitano, B
    Bigos, K
    Bies, R
    Smith, R
    [J]. CRITICAL CARE MEDICINE, 2005, 33 (12) : A171 - A171
  • [8] Pharmacokinetic considerations in critically ill patients
    Escobar, Leslie
    Nella Gai, Maria
    Regueira, Tomas
    Andresen, Max
    [J]. REVISTA MEDICA DE CHILE, 2012, 140 (06) : 780 - 788
  • [9] Pharmacokinetic and Pharmacodynamic Analysis of Ceftazidime/Avibactam in Critically Ill Patients
    Stein, Gary E.
    Smith, Curtis L.
    Scharmen, Amy
    Kidd, James M.
    Cooper, Christopher
    Kuti, Joseph
    Mitra, Subhashis
    Nicolau, David P.
    Havlichek, Daniel H.
    [J]. SURGICAL INFECTIONS, 2019, 20 (01) : 55 - 61
  • [10] Liposomal amphotericin B exposure in critically ill patients: a prospective pharmacokinetic study
    Van Daele, Ruth
    Wauters, Joost
    Elkayal, Omar
    Dreesen, Erwin
    Debaveye, Yves
    Lagrou, Katrien
    de Beer, Yvo
    Maertens, Johan
    Bruggemann, Roger J.
    Spriet, Isabel
    [J]. MEDICAL MYCOLOGY, 2022, 60 (10)